Viromed Medical AG, a medical technology company specializing in cold plasma technology, announced the appointment of Prof. Dr. Michael A. Rubhausen to its Medical Advisory Board, effective immediately. The physicist, who is an expert in spectroscopy and materials research, will provide scientific guidance to support the company's research and development efforts.
Uwe Perbandt, CEO of Viromed Medical AG, expressed enthusiasm about the new appointment: “With Prof. Dr. Michael A. Rubhausen, we are gaining a proven expert in modern spectroscopy and materials research for our Medical Advisory Board. His expertise is intended to help us thoroughly evaluate scientific questions at the intersection of material properties, spectroscopy, and cold plasma, and support our further research work.”
Prof. Dr. Rubhausen heads the Optics Working Group at the Institute of Nanostructure and Solid-State Physics at Universität Hamburg and serves as the Institute’s Managing Director. He is also affiliated with the Center for Free-Electron Laser Science (CFEL). His research focuses on modern spectroscopic methods, including Raman spectroscopy and ellipsometry, which he applies to study superconductors, quantum materials, and biological and inorganic samples at large-scale research facilities such as PETRA III and FLASH.
His interdisciplinary work has resulted in over 180 publications with approximately 4,000 citations, including contributions to prominent journals such as Physical Review Letters, JACS, Angewandte Chemie, Nature Chemistry, Nature Physics, Cellular and Molecular Life Sciences, and Nature Communications. He is also involved in the development of AI-supported analysis workflows for complex and high-dimensional datasets.
Viromed Medical AG specializes in the development, manufacture, and distribution of medical products. Since its stock exchange listing in October 2022, the company has focused on distributing innovative cold plasma technology for medical applications through its wholly owned subsidiary, Viromed Medical GmbH. With a broad customer base in the DACH region and beyond, Viromed aims to advance the use of cold plasma technology in medicine and realize its growth potential.
This appointment underscores Viromed’s commitment to integrating cutting-edge scientific expertise into its operations. The addition of Prof. Dr. Rubhausen is expected to enhance the company's ability to address complex scientific challenges and foster innovation in cold plasma applications. For more information about Viromed Medical AG, visit their website.
